Skip to content

IRIX

IRIDEX Corporation

NASDAQ · Healthcare · Medical - Devices · US

$0.70
−0.10%
Ask drillr

Income statement

MetricTTM2026202420232022
Revenue
Total Revenue51.6M52.7M48.7M51.9M57.0M
Cost of Revenue32.9M33.4M29.2M30.1M31.6M
Gross Profit18.7M19.3M19.5M21.8M25.4M
Operating Expenses
R&D Expense3.8M3.7M5.4M6.8M7.2M
SG&A Expense17.5M18.1M22.4M25.0M25.7M
General & Admin Expense7.1M7.7M9.8M8.7M7.6M
Selling & Marketing Expense10.5M10.4M12.6M16.2M18.2M
Other Expenses158.0K79.0K
Total Operating Expenses21.5M21.9M27.8M31.8M32.9M
Cost and Expenses54.4M55.2M57.0M61.9M64.5M
Operating Income (EBIT)(2.8M)(2.6M)(8.3M)(10.0M)(7.5M)
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense(616.0K)(1.8M)(540.0K)527.0K60.0K
Non-Operating Income (excl Interest)449.0K1.8M540.0K(527.0K)(60.0K)
EBT (Pre-Tax Income)(3.4M)(4.4M)(8.8M)(9.5M)(7.5M)
Income Tax Expense152.0K57.0K68.0K90.0K65.0K
Bottom Line
Net Income(3.5M)(4.4M)(8.9M)(9.6M)(7.5M)
Earnings from Cont. Ops(3.5M)(4.4M)(8.9M)(9.6M)(7.5M)
Earnings from Discont. Ops
Bottom Line Net Income(3.5M)(4.4M)(8.9M)(9.6M)(7.5M)
Per Share
Basic EPS($0.20)($0.26)($0.54)($0.59)($0.47)
Diluted EPS($0.20)($0.26)($0.54)($0.59)($0.47)
Revenue Per Share$2.97$3.06$2.96$3.22$3.57
Shares
Basic Shares Outstanding17.4M17.2M16.4M16.1M15.9M
Diluted Shares Outstanding17.4M17.2M16.4M16.1M15.9M
Profitability Metrics
EBITDA(1.7M)(2.8M)(7.4M)(7.4M)(6.1M)
D&A1.5M1.5M1.4M2.0M1.4M
EBIT(3.2M)(4.4M)(8.8M)(9.5M)(7.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026